AF488-conjugated CD366(TIM-3) Antibody (F38-2E2)

(Synonyms: CD366(TIM-3),CD366-AF488,F38-2E2)

AF488-conjugated CD366(TIM-3) Antibody (F38-2E2) is a Mouse-derived and AF488 conjugated monoclonal antibody, targeting to CD366(TIM-3).

For research use only. We do not sell to patients.
  • Host:

    Mouse

  • Isotype:

    Mouse IgG1,κ

  • Application:

    FC

  • Reactivity :

    Human

  • Formulation:

    Supplied in PBS (pH 7.2) containing 0.1% Proclin300 and protein stabilizer.

  • Conjugation:
    AF488

Applications

Application
FC Info
FC: Flow Cytometry
Dilution Ratio 5 ul per 106 cells in a 100 µl suspension

Product Details

Description

AF488-conjugated CD366(TIM-3) Antibody (F38-2E2) is a Mouse-derived and AF488 conjugated monoclonal antibody, targeting to CD366(TIM-3).

  • Host Mouse
  • Clonality Monoclonal
  • Species Reactivity
    Human
Conjugation

AF488

Modification

Unmodified

Isotype

Mouse IgG1,κ

Product Properties

  • Appearance

    Solution

  • Formulation

    Supplied in PBS (pH 7.2) containing 0.1% Proclin300 and protein stabilizer.

  • Storage & Stability

    Stored at 2-8°C for 1 year, protect from light, do not freeze.

  • Shipping

    Shipping with blue ice.

Background

  • Function

    CD366 (TIM-3) is a cell-surface receptor involved in regulating innate and adaptive immune responses. CD366 (TIM-3) regulates macrophage activation, inhibits Type 1 helper T cell (Th1)-mediated autoimmune and alloimmune responses, and promotes immune tolerance. In CD8+ cells, CD366 (TIM-3) attenuates T-cell receptor (TCR)-induced signaling, leading to reduced IL-2 secretion by blocking NF-κB and NFAT promoter activity.

  • Subcellular Localization

    Cell membrane; Single-pass type I membrane protein; Cell junction; Cell membrane

  • Expression


    Tissue_specificity:Expressed in T-helper type 1 (Th1) lymphocytes. Expressed on regulatory T (Treg) cells after TCR stimulation. Expressed in dendritic cells and natural killer (NK) cells. Expressed in epithelial tissues. Expression is increased on CD4+ and CD8+ T-cells in chronic hepatitis C virus (HCV) infection. In progressive HIV-1 infection, expression is up-regulated on HIV-1-specific CD8 T-cells.

  • Isoforms & Post-Translational Modification

    CD366 (TIM-3) has 2 isomers: Q8TDQ0-1: 33394 Da (predicted); Q8TDQ0-2: 16149 Da (predicted).
    O-glycosylated with core 1 or possibly core 8 glycans;Phosphorylated on tyrosine residues; modestly increased after TCR/CD28 stimulation. Can be phosphorylated in the cytoplasmic domain by FYN (By similarity). Phosphorylation at Tyr-265 is increased by stimulation with ligand LGALS9;Palmitoylated by ZDHHC9 at Cys-296; palmitoylation stabilizes HAVCR2 by preventing binding to E3 ubiquitin ligase SYVN1, thereby suppressing its polyubiquitination and degradation;Ubiquitinated by SYVN1, leading to polyubiquitination and proteasomal degradation

  • Subunit

    Interacts (in basal state T-cells) with VAV1; AKT1/2, LCP2, ZAP70, SYK, PIK3R1, FYN, SH3BP2 and SH2D2A. Interacts (in activated T-cells) with LCK and PLCG.

  • Synonyms

    CD366(TIM-3),CD366-AF488,F38-2E2

AF488-conjugated CD366(TIM-3) Antibody (F38-2E2) Related Classifications

MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00